PharmatrophiX

    OverviewSuggest Edit

    PharmatrophiX is a company developing small molecule drugs for neurodegenerative and other diseases. It uses a PTX technology to create drugs modulating neurotrophin receptor signaling. The company also offers P75 neurotrophin receptor program preventing neurodegenerative signaling and promoting regenerating one.
    TypePrivate
    Founded2005
    Websitepharmatrophix.com

    Latest Updates

    Cybersecurity ratingAMore

    PharmatrophiX Financials and Metrics

    Summary Metrics

    Founding Date

    2005

    PharmatrophiX latest funding size

    $10.30 m
    Show all financial metrics

    PharmatrophiX Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    95/100

    SecurityScorecard logo

    PharmatrophiX Online and Social Media Presence

    Embed Graph

    PharmatrophiX Frequently Asked Questions

    • When was PharmatrophiX founded?

      PharmatrophiX was founded in 2005.

    • Who are PharmatrophiX competitors?

      Competitors of PharmatrophiX include Supernus Pharmaceuticals, Verge Genomics and Azevan Pharmaceuticals.